Accepted for/Published in: JMIR Formative Research
Date Submitted: Mar 17, 2022
Date Accepted: Oct 25, 2022
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Does the use of connected devices contribute to the empowerment of patients with cystic fibrosis for the management of their pulmonary exacerbations? A grounded theory from the MucoExocet study
ABSTRACT
Background:
Early detection of pulmonary exacerbations (PEx) in patients with cystic fibrosis (CF) is important to quickly trigger treatment and reduce respiratory damage. An intervention was designed in the frame of the MucoExocet research study providing CF patients with connected devices and educating them to detect and react to their early signs of PEx.
Objective:
Identify the contributions and conditions of home monitoring in relation with their care teams, from the users’ point of view, to detect early and treat PEx. This article focuses on the patients’ experience as first and main users of home monitoring.
Methods:
A qualitative study has been conducted as part of the overall research project to explore patients’ and professionals’ experience of the intervention. We interviewed the patients who completed the 2-year study using semi-structured guides and conducted focus groups with the care teams. All interviews were recorded and transcribed verbatim. Their educational material was collected. A grounded analysis was done by two researchers.
Results:
Eighteen patients completed the study. Three main categories emerged from the patients’ verbatims and were also found in the professionals’: (1) task technology fit (TTF) reflecting reliability, ease of use, accuracy of data, and support of the technology; (2) patient empowerment through technology, grouping patients’ learnings, validation of their perception of exacerbation, assessment of treatment efficacy, awareness of healthy behaviours, ability to react to PEx signs in relation with their care team; (3) usage reflecting a continuous or intermittent utilisation, the perceived usefulness balanced with cumbersome measurements, routinisation, and personalisation of the measurement process, and the way data have been shared with the care team. Furthermore, three relations have been highlighted between the categories that reflect necessary conditions for patient empowerment through the use of technology.
Conclusions:
We discuss a theorisation of the process of patient empowerment through the use of connected devices and call for further research to verify or amend it in other contexts of technology, illnesses, and care organisations.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.